why choose us

First received: June 27, 2023

Clinical Trial: Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Systemic Lupus Erythematosus

Study Type: OBSERVATIONAL


Official Title: ERYTHRO Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs.

Brief Summary: The ERYTHRO study is a retrospective medical chart review study of patients in the AMANA and ATUc Early Access Programs (EAPs) across a number of countries, to assess anifrolumab usage and patient experience in treating SLE in a real-world setting.Since patient safety data are already collected and reported according to regulatory requirements through EAPs, this study will not collect safety data.

Read more